ASAM Provider Guide

National Practice Guideline

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1019954

Contents of this Issue

Navigation

Page 17 of 23

16 Treatment Î Patients on methadone for the treatment of OUD and who are admitted for surgery may require additional short-acting opioid pain relievers. • The dose of pain relievers prescribed may be higher due to tolerance. Î Temporarily increasing buprenorphine dosing may be effective for mild acute pain. Î For severe acute pain, discontinuing buprenorphine and commencing on a high potency opioid (such as fentanyl) is advisable. • Monitor patients closely and consider additional interventions such as regional anesthesia. Î The decision to discontinue buprenorphine prior to an elective surgery should be made in consultation with the attending surgeon and anesthesiologist. • If it is decided that buprenorphine should be discontinued prior to surgery, this should occur 24–36 hours in advance of surgery and restarted post-operatively when the need for full opioid agonist analgesia has passed. Î Patients on naltrexone will not respond to opioid analgesics in the usual manner. Therefore, it is recommended that mild pain be treated with NSAIDs and moderate to severe pain be treated with ketorolac on a short-term basis. Î Oral naltrexone should be discontinued 72 hours prior to surgery and extended-release injectable naltrexone should be discontinued 30 days prior to an anticipated surgery. Adolescents Î Clinicians should consider treating adolescents who have OUD using the full range of treatment options, including pharmacotherapy. Î Opioid agonists (methadone and buprenorphine) and antagonists (naltrexone) may be considered for treatment of OUD in adolescents. • Age is a consideration in treatment, and federal laws and FDA approvals need to be considered for patients under age 18. Î Psychosocial treatment is recommended in the treatment of adolescents with OUD. Î Concurrent practices to reduce infection (e.g., sexual risk reduction interventions), are recommended as components of comprehensive treatment for the prevention of sexually transmitted infections and blood-borne viruses. Î Adolescents may benefit from treatment in specialized treatment facilities that provide multidimensional services.

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline